A CD25- positive population of activated B1 cells expresses LIFR and responds to LIF

Frontiers in Immunology

Volumn 2, Issue MAR, 2011, Pages

  Tumang, Joseph R ^a,b   Holodick, Nichol E ^a   Vizconde, Teresa C ^a   Kaku, Hiroaki ^a   Francés, Rubén ^a,c   Rothstein, Thomas L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b EMD Serono Research Center   (United States)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

B1 cells; CD25; LIF receptor; Signaling

Indexed keywords

EID: 84858441151     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00006     Document Type: Article

References (72)

1. Alugupalli, K. R., Leong, J. M., Woodland, R. T., Muramatsu, M., Honjo, T., and Gerstein, R. M. (2004). B1b lymphocytes confer T cellindependent long-lasting immunity. Immunity 21, 379-390.
2. Arnold, L. W., Pennell, C. A., McCray, S. K., and Clarke, S. H. (1994). Development of B-1 cells: segregation of phosphatidylcholine-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179, 1585-1595.
3. Auernhammer, C. J., and Melmed, S. (2001). The central role of SOCS-3 in integrating the neuroimmunoendocrine interface. J. Clin. Invest. 108, 1735-1740.
4. Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. E., Herzenberg, L. A., and Chen, J. (2000). B-1 and B2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192, 271-280.
5. Benedict,C. L.,and Kearney,J. F. (1999). Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 10, 607-617.
6. Berland, R., and Wortis, H. H. (2002). Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300.
7. Binder,C. J.,and Silverman,G. J. (2005). Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin. Immunopathol. 26, 385-404.
8. Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C., and Chen, J. (1998). A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188, 2381-2386.
9. Bowman, T., Garcia, R., Turkson, J., and Jove, R. (2000). STATs in oncogenesis. Oncogene 19, 2474-2488.
10. Briles, D. E., Nahm, M., Schroer, K., Davie, J., Baker, P., Kearney, J., and Barletta, R. (1981). Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153, 694-705.
11. Bromberg, J., and Darnell, J. E., Jr. (2000). The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
12. Brunn, G. J., Falls, E. L., Nilson, A. E., and Abraham, R. T. (1995). Proteintyrosine kinase-dependent activation of STAT transcription factors in interleukin-2or interleukin-4stimulated T lymphocytes. J. Biol. Chem. 270, 11628-11635.
13. Bruun, C., Heding, P. Eo., Ronn, S. G., Frobose,H.,Rhodes,C. J.,Mandrup Poulsen, T., and Billestrup, N. (2009). Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells. Mol. Cell. Endocrinol. 311, 32-38.
14. Calo, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., and Russo, A. (2003). STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157-168.
15. Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K., and Dalton, S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132, 885-896.
16. Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., Carroll, M. C., and Rajewsky, K. (2004). B cell receptor signal strength determines B cell fate. Nat. Immunol. 5, 317-327.
17. Cong, Y. Z., Rabin, E., and Wortis, H. H. (1991). Treatment of murine CD5B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 3, 467-476.
18. Dimitriou, I. D., Clemenza, L., Scotter, A. J., Chen, G., Guerra, F. M., and Rottapel, R. (2008). Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224, 265-283.
19. Duber, S., Hafner, M., Krey, M., Lienenklaus, S., Roy, B., Hobeika, E., Reth, M., Buch, T., Waisman, A., Kretschmer, K., and Weiss, S. (2009). Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114, 4960-4967.
20. Fischer, G. M., Solt, L. A., Hastings, W. D., Yang, K., Gerstein, R. M., Nikolajczyk, B. S., Clarke, S. H., and Rothstein, T. L. (2001). Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell. Immunol. 213, 62-71.
21. Frances, R., Tumang, J. R., Kaku, H., Gurdak, S. M., and Rothstein, T. L. (2006). B-1 cells express transgelin 2: unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells. Mol. Immunol. 43, 2124-2129.
22. Frances, R., Tumang, J. R., and Rothstein, T. L. (2007). Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells. Int. Immunol. 19, 59-65.
23. Frank, D. A., Robertson, M. J., Bonni,A., Ritz, J., and Greenberg, M. E. (1995). Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc. Natl.Acad. Sci. U.S.A. 92,7779- 7783.
24. Gu, H., Forster, I., and Rajewsky, K. (1990). Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J. 9, 2133-2140.
25. Hamilton, A. M., Lehuen, A., and Kearney, J. F. (1994). Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int. Immunol. 6,355-361.
26. Hardy, R. R. (2006). B-1 B cell development. J. Immunol. 177, 2749-2754.
27. Hardy, R. R., Carmack, C. E., Shinton, S. A., Riblet, R. J., and Hayakawa, K. (1989). A single VH gene is utilized predominantly in antiBrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142, 3643-3651.
28. Hardy, R. R., and Hayakawa, K. (2001). B cell development pathways. Annu. Rev. Immunol. 19, 595-621.
29. Hayakawa, K., Hardy, R. R., and Herzenberg, L. A. (1986). Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol. 16, 450-456.
30. Hayakawa, K., Hardy, R. R., Parks, D. R., and Herzenberg, L. A. (1983). The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157, 202-218.
31. Herzenberg, L.A. (2000). B-1 cells: the lineage question revisited. Immunol. Rev. 175, 9-22.
32. Holodick, N. E., Repetny, K., Zhong, X., and Rothstein, T. L. (2009a). Adult BM generates CD5(B1 cells containing abundant N-region additions. Eur. J. Immunol. 39, 2383-2394.
33. Holodick, N. E., Tumang, J. R., and Rothstein, T. L. (2009b). Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol. Immunol. 46, 3029-3036.
34. Holodick, N. E., Tumang, J. R., and Rothstein, T. L. (2010). Immunoglobulin secretion by B1 cells: differential intensity and interferon response factor 4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur. J. Immunol. 40, 3007-3016.
35. Kantor, A. B., Stall, A. M., Adams, S., and Herzenberg, L. A. (1992). Differential development of progenitor activity for three B-cell lineages. Proc. Natl.Acad. Sci. U.S.A. 89,3320- 3324.
36. Kantor, A. B., Stall, A. M., Adams, S., Watanabe, K., and Herzenberg, L. A. (1995). De novo development and self-replenishment of B cells. Int. Immunol. 7, 55-68.
37. Karras, J. G.,Wang, Z., Huo, L., Howard, R. G., Frank, D. A., and Rothstein, T. L. (1997). Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185, 1035-1042.
38. Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., and Dalla-Favera, R. (2006). Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7, 773-782.
39. Krutzik, P. O., and Nolan, G. P. (2006). Fluorescent cell barcoding in flow cytometry allows highthroughput drug screening and signaling profiling. Nat. Methods 3, 361-368.
40. Lalor, P. A., Herzenberg, L. A., Adams, S., and Stall, A. M. (1989). Feedback regulation of murine Ly-1 B cell development. Eur. J. Immunol. 19, 507-513.
41. Lin, K. I., Tunyaplin, C., and Calame, K. (2003). Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194, 19-28.
42. Minami, Y., Kono, T., Miyazaki, T., and Taniguchi, T. (1993). The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11, 245-268.
43. Montecino-Rodriguez, E., Leathers, H., and Dorshkind, K. (2006). Identification of a B-1 B cellspecified progenitor. Nat. Immunol. 7, 293-301.
44. Morris, D. L., and Rothstein, T. L. (1993). Abnormal transcription factor induction through the surface immunoglobulin M receptor of B1 lymphocytes. J. Exp. Med. 177, 857-861.
45. Morris, D. L., and Rothstein, T. L. (1994). Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes. Int. Immunol. 6, 1011-1016.
46. Muraguchi, A., Kehrl, J. H., Longo, D. L., Volkman, D. J., Smith, K. A., and Fauci, A. S. (1985). Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J. Exp. Med. 161, 181-197.
47. Murphy, T. P., Kolber, D. L., and Rothstein, T. L. (1990). Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes. Eur. J. Immunol. 20, 1137-1142.
48. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S., and Kishimoto, T. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
49. Nielsen, M., Svejgaard, A., Skov, S., and Odum, N. (1994). Interleukin2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 24, 3082-3086.
50. Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060.
51. Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H., and Zinkernagel, R. M. (1999). Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159.
52. Pennell, C. A., Mercolino, T. J., Grdina, T. A., Arnold, L. W., Haughton, G., and Clarke, S. H. (1989). Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur. J. Immunol. 19, 1289-1295.
53. Rolink, A., Grawunder, U., Winkler, T. H., Karasuyama, H., and Melchers, F. (1994). IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257-1264.
54. Rothstein, T. L. (2002). Cutting edge commentary: two B-1 or not to be one. J. Immunol. 168, 4257-4261.
55. Rothstein, T. L., and Kolber, D. L. (1988a). Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. J. Immunol. 141, 4089-4093.
56. Rothstein, T. L., and Kolber, D. L. (1988b). Peritoneal B cells respond to phorbol esters in the absence of comitogen. J. Immunol. 140, 2880-2885.
57. Savitsky, D., and Calame, K. (2006). B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J. Exp. Med. 203, 2305-2314.
58. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., and Hilton, D. J. (1997). A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.
59. Su, S. D., Ward, M. M., Apicella, M. A., and Ward, R. E. (1991). The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J. Immunol. 146, 327-331.
60. Tanguay, D. A., Colarusso, T. P., Doughty, C., Pavlovic-Ewers, S., Rothstein, T. L., and Chiles, T. C. (2001). Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets. J. Immunol. 166, 4273- 4277.
61. Tanguay,D.A.,Colarusso,T. P.,Pavlovic, S., Irigoyen, M., Howard, R. G., Bartek, J., Chiles, T. C., and Rothstein, T. L. (1999). Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J. Exp. Med. 189, 1685-1690.
62. Taupin, J. L., Pitard, V., Dechanet, J., Miossec,V., Gualde, N., and Moreau, J. F. (1998). Leukemia inhibitory factor: part of a large ingathering family. Int. Rev. Immunol. 16, 397-426.
63. Tumang, J. R., Frances, R., Yeo, S. G., and Rothstein, T. L. (2005). Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J. Immunol. 174, 3173-3177.
64. Tumang, J. R., Hastings, W. D., Bai, C., and Rothstein, T. L. (2004). Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics. Eur. J. Immunol. 34, 2158-2167.
65. Tumang, J. R., Owyang, A., Andjelic, S., Jin, Z., Hardy, R. R., Liou, M. L., and Liou, H. C. (1998). c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur. J. Immunol. 28, 4299-4312.
66. Wang, H., and Clarke, S. H. (2004). Regulation of B-cell development by antibody specificity. Curr. Opin. Immunol. 16, 246-250.
67. Wang, Z., Morris, D. L., and Rothstein, T. L. (1995). Constitutive and inducible levels of egr-1 and c-myc early growth response gene expression in self-renewing B-1 lymphocytes. Cell. Immunol. 162, 309-314.
68. Wong, S. C., Chew, W. K., Tan, J. E., Melendez, A. J., Francis, F., and Lam, K. P. (2002). Peritoneal CD5(B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277, 30707-30715.
69. Wortis, H. H., and Berland, R. (2001). Cutting edge commentary: origins of B-1 cells. J. Immunol. 166, 2163- 2166.
70. Yoshimura, A., Naka, T., and Kubo, M. (2007). SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465.
71. Zhong, X., Gao, W., Degauque, N., Bai, C., Lu, Y., Kenny, J., Oukka, M., Strom, T. B., and Rothstein, T. L. (2007a). Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37, 2400-2404.
72. Zhong, X., Tumang, J. R., Gao, W., Bai, C., and Rothstein, T. L. (2007b). PDL2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol. 37, 2405-2410.